kodan CHX farblos

kodan CHX farblos is a medicine authorised by Swissmedic under authorisation number 69847. The authorisation holder is Schülke & Mayr AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 23 April 2026 and the authorisation is limited until 22 April 2031. ATC code D08AC52 places the medicine in the group Antiseptics and disinfectants.

  • Dispensing category D
  • Authorisation number 69847
  • ATC D08AC52
  • Synthetic medicines
Authorisation data
Authorisation number69847
Namekodan CHX farblos
Full namekodan CHX farblos, Lösung zur Anwendung auf der Haut
Authorisation holderSchülke & Mayr AG
Medicinal product codeSynthetic medicines
Dispensing categoryD · No prescription, with advice
ATC codeD08AC52
First authorisation23 April 2026
Authorisation validity22 April 2031
Strengths
No.NameDispensing categoryAuthorisation date
1kodan CHX farblos, Lösung zur Anwendung auf der HautD23 April 2026
2kodan CHX gefärbt, Lösung zur Anwendung auf der HautD23 April 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
150mlD08AC5210.09.1.D
2125mlD08AC5210.09.1.D
3250mlD08AC5210.09.1.D
450mlD08AC5210.09.1.D
5250mlD08AC5210.09.1.D

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is kodan CHX farblos authorised in Switzerland?

Yes. kodan CHX farblos is authorised by Swissmedic under authorisation number 69847, data as of 01 September 2026. The authorisation is limited until 22 April 2031.

Which dispensing category does kodan CHX farblos have?

kodan CHX farblos is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.

Who is the authorisation holder of kodan CHX farblos?

The authorisation holder is Schülke & Mayr AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com